XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.2

Revenue (Tables)

6 Months Ended

Jun. 30, 2023

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregated Revenue

The following table presents our disaggregated revenue for the periods presented (in thousands):

		Three Months Ended June 30,								Six Months Ended June 30,
		2023				2022				2023				2022
Immune Medicine revenue
Service revenue		$	5,508			$	7,296			$	12,610			$	14,409
Collaboration revenue			17,536				15,082				26,654				28,785
Total Immune Medicine revenue			23,044				22,378				39,264				43,194
MRD revenue
Service revenue			25,882				20,282				47,309				35,086
Regulatory milestone revenue			—				1,000				—				4,000
Total MRD revenue			25,882				21,282				47,309				39,086
Total revenue		$	48,926			$	43,660			$	86,573			$	82,280

X

- Definition

Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 606
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 5
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147479806/606-10-50-5

+ Details

Name:	us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration